In adipose tissue, aquaglyceroporins, and in particular AQP7, represent potential drug target for the treatment of obesity and metabolic syndrome (Frühbeck et al., 2006; Maeda, 2012; Verkman, 2012). The gene discussed is AQP7; the disease is metabolic syndrome.